IRIS
NATILE, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.063
AS - Asia 6.234
EU - Europa 4.481
SA - Sud America 1.644
AF - Africa 215
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 30.659
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.900
SG - Singapore 2.467
CN - Cina 1.759
BR - Brasile 1.307
RU - Federazione Russa 1.216
SE - Svezia 817
HK - Hong Kong 762
UA - Ucraina 452
FI - Finlandia 394
DE - Germania 392
VN - Vietnam 354
IT - Italia 347
FR - Francia 315
GB - Regno Unito 256
IN - India 190
BD - Bangladesh 115
AR - Argentina 103
IQ - Iraq 86
ID - Indonesia 64
CA - Canada 63
TR - Turchia 63
CO - Colombia 58
MX - Messico 58
EC - Ecuador 56
ZA - Sudafrica 55
SA - Arabia Saudita 51
BE - Belgio 47
PK - Pakistan 45
VE - Venezuela 45
IE - Irlanda 44
JP - Giappone 43
CI - Costa d'Avorio 41
ES - Italia 37
PL - Polonia 32
MA - Marocco 30
UZ - Uzbekistan 29
PH - Filippine 25
AT - Austria 24
CL - Cile 24
NL - Olanda 23
TN - Tunisia 22
MY - Malesia 21
KZ - Kazakistan 20
CZ - Repubblica Ceca 18
KE - Kenya 18
IR - Iran 17
JO - Giordania 16
PY - Paraguay 16
AU - Australia 15
BO - Bolivia 14
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 11
DZ - Algeria 10
OM - Oman 10
PE - Perù 10
CR - Costa Rica 9
EG - Egitto 9
ET - Etiopia 9
IL - Israele 9
LT - Lituania 9
NG - Nigeria 8
PT - Portogallo 8
UY - Uruguay 8
JM - Giamaica 7
NP - Nepal 7
AL - Albania 6
HR - Croazia 6
HU - Ungheria 6
PA - Panama 6
PS - Palestinian Territory 6
SY - Repubblica araba siriana 6
BG - Bulgaria 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
LB - Libano 5
LK - Sri Lanka 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
GE - Georgia 4
KG - Kirghizistan 4
NI - Nicaragua 4
DM - Dominica 3
EU - Europa 3
GR - Grecia 3
KR - Corea 3
RO - Romania 3
SN - Senegal 3
CG - Congo 2
KH - Cambogia 2
LY - Libia 2
MK - Macedonia 2
MM - Myanmar 2
MN - Mongolia 2
MU - Mauritius 2
PR - Porto Rico 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 30.630
Salva come PNG Salva come JPEG
Città #
Fairfield 2.572
Woodbridge 1.714
Ashburn 1.627
Chandler 1.282
Singapore 1.236
Houston 1.167
Seattle 1.049
Jacksonville 975
Cambridge 882
Wilmington 782
Hong Kong 754
San Jose 695
Nyköping 655
Ann Arbor 610
Beijing 356
Nanjing 355
Lawrence 287
Roxbury 283
Lauterbourg 256
New York 243
Boardman 206
Princeton 186
Des Moines 175
Bari 157
Dallas 146
Los Angeles 142
Helsinki 140
Ho Chi Minh City 131
Brooklyn 121
San Diego 105
São Paulo 104
Nanchang 103
Dearborn 101
Inglewood 98
Santa Clara 89
Shenyang 84
Jiaxing 75
Buffalo 74
Hebei 72
Hanoi 71
Rio de Janeiro 52
Tianjin 50
Brussels 47
Council Bluffs 46
Abidjan 41
Tokyo 41
London 40
Baghdad 39
Moscow 39
Dublin 38
Kunming 38
Munich 38
Changsha 36
Chicago 35
Jinan 32
Shanghai 28
Jakarta 27
Pune 27
San Francisco 27
Guangzhou 26
Johannesburg 26
Paris 26
Warsaw 26
Tashkent 25
Curitiba 24
Stockholm 24
Atlanta 23
Quito 23
Medellín 22
San Mateo 22
The Dalles 22
Washington 22
Wuhan 22
Zhengzhou 22
Columbus 21
Belo Horizonte 20
Mexico City 20
Boston 19
Brasília 19
Frankfurt am Main 19
Orem 18
Brno 17
Denver 17
Mumbai 17
Norwalk 17
Riyadh 17
Chennai 16
Falkenstein 16
Montreal 16
Nairobi 16
Dhaka 15
Nuremberg 15
Toronto 15
Amman 14
Guayaquil 14
Phoenix 14
Amsterdam 13
Ardabil 13
Cape Town 13
Haiphong 13
Totale 21.660
Salva come PNG Salva come JPEG
Nome #
The First Example of a Dinuclear Platinum(III) Complex with Three Bridging Ligands 784
Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage 221
Amyloid Transition of Ubiquitin on Silver Nanoparticles Produced by Pulsed Laser Ablation in Liquid as a Function of Stabilizer and Single-Point Mutations 209
Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA 207
Mechanistic and structural basis for inhibition of copper trafficking by platinum anticancer drugs 207
A Pt(IV) prodrug of kiteplatin with the bone-targeting pyrophosphate ligand 194
Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands 182
A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO) 179
Addition versus substitution in the reaction of diiodo(2,9-dimethyl-1,10-phenanthroline)platinum(II) with aromatic bases. X-ray crystal structures of the substitution products with 2-amino-pyridine and 1-methyl-cytosine 177
Activation of platinum(IV) prodrugs by cytochrome c and characterization of the protein binding sites 177
A new case of polymorphism in platinum(II) complexes: [PtBr2(2,9-dimethyl-1,10-phenanthroline)]? 175
Silver and gold nanoparticles produced by pulsed laser ablation in liquid to investigate their interaction with Ubiquitin 164
Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands 160
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 158
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 158
Addition of Hydroxide, Alkoxide, and Carboxylate Anions to Platinum-bonded Ethylene 157
Aggregation Pathways of Native-Like Ubiquitin Promoted by Single-Point Mutation, Metal Ion Concentration, and Dielectric Constant of the Medium 156
Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs. 154
Activation of Ketones by Electrophilic Metal Complexes. Synthesis of Some Ketonyl Platinum(II) Complexes and X-Ray Crystal Structure of [PtCl{CH2C(O)CH3}(1,10-phenanthroline)]·1/2Y (Y = H2O or CH2Cl2) 153
Isomerism of amides coordinated to platinum. X-ray crystal structure of dichloro-bisacetamide-platinum(II) 153
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds 150
Effect of chirality in platinum drugs 150
A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues 149
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir 148
A NMR, X-ray, and DFT combined study on the regio-chemistry of nucleophilic addition to platinum(II) coordinated terminal olefins 147
Copper binding to naturally occurring, lactam form of angiogenin differs from that to recombinant protein, affecting their activity 147
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 145
Lantern-Shaped” Platinum(III) Complexes with Axially Bound 9-Ethylguanine or 1-Methylcytosine (L) of General Formula [Pt2{HN=C(But)O}4L2](NO3)2 145
Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione 145
Insertion of terminal alkyne into Pt-N bond of the square planar [PtI2(Me2phen)] complex 144
A General Procedure for the Selective Oxidation of Sulfides to Sulfoxides by Nitric Acid: Tetrabromoaurate(III) Catalyst in a Biphasic System 143
DNA fragment conformations in adducts with Kiteplatin 143
A Seven-Membered Platinum-Amino-Amidine Metallacycle. X-ray Structure of cis-[Pt(NH=CPhNButCH2CH2NHBut)Cl2].´Me2CO 139
Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum(II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum(II) 138
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position 138
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs affording an oxaliplatin analogue that overcomes cancer resistance 137
Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)] 136
Cisplatin reacts with histone H1 and the adduct forms a ternary complex with DNA 135
C hiral Discrimination in Platinum Anticancer Drugs 134
Biomimetic hydroxyapatite/drug nanocrystals as potential bone substitutes with anti-tumour drug delivery properties 134
Computational metallomics of the anticancer drug cisplatin 134
Chiral discrimination in the formation reaction and at equilibrium for N,N,N ',N '-tetramethyl-1,2-diaminocyclohexane-PtG(2) complexes 133
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 133
Reaction of Histone H1 with trans-Platinum Complexes and the Effect on DNA Platination 132
Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides 131
Synthesis and X-ray Structural Characterization of Two Unbridged Diplatinum(III) Compounds: cis- and trans-Bis[bis(1-imino-1-methoxyethane)trichloroplatinum(III)]. Transient Species in the Oxidation of Platinum(II) to Platinum(IV) 131
Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy 131
Hydroxyapatite nanocrystals as a smart, pH sensitive, delivery system for kiteplatin 131
Cytotoxic trans-oriented iminoether platinum complexes – Kinetics of binding to DNA oligonucleotides determined by 15N NMR spectroscopy 130
Atropisomerization of cis-Bis(5'GMP)-Platinum(II)-Diamine complexes with Non-C2-symmetrical asymmetric diamine ligands containing NH groups directed to one side of the coordination plane 130
A new polymorph of dichlorido(1,10-phenanthroline)platinum(II) 129
A Molecular Tool for Measuring the Electron-Acceptor Ability of Ligands from Crystallographic Data 129
Conformer distribution in (cis-1,4-DACH)bis(guanosine5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin 129
Aiding Factors in the Formation of Azaplatinacyclobutane Rings – X-ray and Crystal Structure of [Pt{CH(Ph)CH2NEt2-κC,κN}(N,N,N′,N′-tetramethylethylenediamine)]+ and of Its Open-Chain Precursor 128
Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor 127
NMR and X-ray characterization of a platinum(II) complex with (−)sparteine 126
An updated view of translocator protein (TSPO) 126
C60@Lysozyme: Direct Observation by Nuclear Magnetic Resonance of a 1:1 Fullerene Protein Adduct 126
Reactivity of kiteplatin with S-donor biomolecules and nucleotides 125
Structural biology of cisplatin complexes with cellular targets: the adduct with human copper chaperone Atox1 in aqueous solution 125
An Updated View of Cisplatin Transport 125
Single-Stranded Oligonucleotide Adducts Formed by Pt Complexes Favoring Left-Handed Base Canting: Steric Effect of Flanking Residues and Relevance to DNA Adducts Formed by Pt Anticancer Drugs 124
A novel head-to-head conformer of d(GpG) cross-linked by Pt: New light on the conformation of such cross-links formed by Pt anticancer drugs 124
Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours 123
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 123
The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex 123
Copper Homeostasis in Humans and Bacteria 122
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine 121
Synthesis and Characterization of Platinum(II) Complexes of Diethyl [(Methylsulfinyl)methyl]phosphonate: Potential Drugs against Bone Tumors 121
Five-coordinate alkene complexes of palladium(II) and platinum(II) 120
Insights into the Molecular Mechanisms of Protein Platination from a Case Study: The Reaction of Anticancer Platinum(II) Iminoethers with Horse Heart Cytochrome c 120
Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent 120
Potentiation of cytotoxic action of cis-[PtCl2(NH3)(1M7AI)] by UVA irradiation. Mechanistic insights 120
NMR and X-ray Structural Characterization of a Cisplatin Analogue Able To Slow Down the Pt−N7 Rotation of a Coordinated Guanine Base by a Billion-Fold Times: 2,2'-Bipiperidine(dimethylmalonato)platinum(II) Complex 119
Synthesis, characterization, and in vitro evaluation of a new TSPO-selective bifunctional chelate ligand 119
Platinum(II) complexes with the diethyl(aminomethyl)phosphonate ligand (amp): characterization, properties and unusual solution behavior 119
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 119
Endocyclic versus exocyclic N-coordination to platinum(II) of some nitro-9-[(2-dialkylaminoethyl)amino]acridines 118
Platinum amides from platinum nitriles: X-ray crystal structure of trans-dichloro-bis(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 117
Antitumor trans Platinum Complexes can Form Cross-Links with Adjacent Purine Groups 117
Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions 117
Insertion of alkynes into Pt-X bonds of square planar [PtX2(N-N)] (X = Cl, Br, I) complexes 116
Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring PtII chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand 116
Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1 116
Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B 115
Platinum Complexes with the Novel Ligand Diethyl [(Methylsulfinyl)- methyl]phosphonate (SMP): Solid-State Characterization of Potassium Trichloro(SMP)platinum(II) which, in Solution, Gives Dichloro(SMP)- platinum(II) and Potassium Chloride 115
H/D exchange at sp(3) carbons in the coordination sphere of platinum(II) 114
Synthesis, characterization, and in vitro evaluation of new coordination complexes of platinum(II) and rhenium(I) with a ligand targeting the translocator protein (TSPO) 114
X-ray structure and circular dichroism of pure rotamers of Bis[Guanosine-5'-monophosphate(-1)](N,N,N',N'-tetramethylcyclohexyl-1,2-diamine)platinum(II) complexes that have R,R and S,S configurations at the asymmetric diamine 113
Synthesis and structural characterization of isomeric "lantern-shaped" platinum(III) complexes of formula [Pt2(PPh3)X{N(H)C(R)O}4](NO3)2 (X=PPh3, H2O) 113
Chirality-Controlling Chelate (CCC) Ligands in Analogs of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG2 with CCC = N,N'-Dimethyl-2,3-diaminobutane 113
Synthesis and characterisation of the amidine complexes trans-[PtCl(NH3){HN=C(NH2)R}2]Cl (R = Me, Ph, CH2Ph) derived from addition of NH3 to the coordinated nitriles in trans-[PtCl2(NCR)2] 112
Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG Box Proteins and Nucleotide Excision Repair of these adducts 111
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 111
Role of metal ions and hydrogen bond acceptors in the tautomeric equilibrium of nitro-9[(alkylamino)amino]-acridine drugs 111
Unusual reactivity at a platinum center determined by the ligands and the solvent environment 111
Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach 111
Mono- and bis-guanosine adducts of platinum complexes with carrier ligands having in-plane steric bulk: The case of 1,10-phenanthroline and 2,9-dimethyl-1,10-phenanthroline 111
Monitoring Interactions inside Cells by Advanced Spectroscopies: Overview of Copper Transporters and Cisplatin 111
Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals 111
Totale 14.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.913
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021839 0 0 0 0 0 0 0 0 0 452 234 153
2021/20222.087 71 284 21 72 94 157 94 113 203 156 359 463
2022/20233.338 568 310 207 326 440 400 22 406 502 19 82 56
2023/20241.087 95 173 46 91 104 295 28 64 16 21 5 149
2024/20253.983 175 67 379 132 104 298 339 301 175 196 552 1.265
2025/20267.655 1.151 406 512 972 863 487 967 225 1.454 618 0 0
Totale 31.098